MARCH7 Protein

MARCH7 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MARCH7 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Membrane-Associated Ring-CH-Type Finger 7</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MARCH7</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2G9</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>75.3 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Endoplasmic Reticulum, Mitochondria</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MARCH E3 ubiquitin ligase family (MARCH1-11)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Basal Ganglia, Cerebellum</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">54 edges</a></td>
</tr>
</table>

MARCH7 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MARCH7 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Membrane-Associated Ring-CH-Type Finger 7</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MARCH7</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2G9</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>75.3 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Endoplasmic Reticulum, Mitochondria</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MARCH E3 ubiquitin ligase family (MARCH1-11)</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Basal Ganglia, Cerebellum</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">54 edges</a></td>
</tr>
</table>

MARCH7 (Membrane-Associated Ring-CH-Type Finger 7) is an E3 ubiquitin ligase that plays important roles in the regulation of immune function, protein quality control, and cellular signaling. As a member of the MARCH family of E3 ubiquitin ligases, MARCH7 catalyzes the covalent attachment of ubiquitin to target proteins, thereby regulating their stability, localization, and function. Emerging research suggests that MARCH7 may have important implications for neurodegenerative diseases through its roles in protein homeostasis and mitochondrial quality control[@bartee2004].

Overview

MARCH7 is a cytosolic E3 ubiquitin ligase that localizes to multiple cellular compartments, including the cytoplasm, endoplasmic reticulum (ER), and mitochondria. The protein is expressed in various tissues, with particularly high expression in immune cells and [neurons](/entities/neurons). MARCH7-mediated ubiquitination regulates multiple cellular processes relevant to neurodegeneration, including protein degradation, immune signaling, and mitochondrial dynamics[@goto2010].

Protein Information

Structure

MARCH7 contains several functional domains characteristic of the MARCH family[@liu2014]:

Normal Function

Ubiquitination System

The [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) (UPS) is the primary mechanism for targeted protein degradation in eukaryotic cells. MARCH7 functions as an E3 ligase in this system[@deng2020]:

• Ubiquitin Cascade: MARCH7 transfers ubiquitin from an E2 conjugating enzyme to lysine residues on target proteins
• Chain Types: Catalyzes formation of different ubiquitin chain types (K48, K63) depending on cellular context
• Substrate Recognition: Recognizes specific substrates through protein-protein interaction motifs

Protein Quality Control

MARCH7 plays a critical role in cellular protein quality control[@song2018]:

Immune Regulation

MARCH7 has established roles in immune system regulation:

• T cell Activation: Regulates T cell receptor signaling and activation
• Immune Synapse Formation: Modulates immune cell interactions
• Cytokine Signaling: Influences inflammatory signaling pathways

Mitochondrial Dynamics

Emerging evidence suggests MARCH7 participates in mitochondrial quality control[@youle2012]:

• Mitophagy: May contribute to selective [autophagy](/entities/autophagy) of damaged mitochondria
• Mitochondrial Protein Turnover: Regulates degradation of mitochondrial proteins
• [Mitochondrial Dynamics](/entities/mitochondrial-dynamics): Influences fission and fusion processes

Role in Disease

Alzheimer's Disease

MARCH7 may be implicated in Alzheimer's disease pathogenesis through several mechanisms[@ciechanover2015]:

Parkinson's Disease

MARCH7's role in protein quality control is particularly relevant to PD[@ebrahimifakhari2012]:

Amyotrophic Lateral Sclerosis (ALS)

MARCH7 may contribute to ALS pathogenesis:

• Protein Aggregate Clearance: Altered ubiquitination affects [TDP-43](/proteins/tdp-43) and other protein aggregates
• Mitochondrial Dysfunction: Contributes to mitochondrial protein quality control
• Neuroinflammation: Modulates immune responses in motor neuron disease

Cancer

Dysregulated MARCH7 expression has been reported in various cancers:

• Oncogenic Properties: May promote tumor cell proliferation
• Immune Evasion: Altered immune regulation may aid tumor escape
• Therapeutic Target: MARCH7 inhibitors being explored in oncology

Therapeutic Targeting

Small Molecule Inhibitors

• Development Status: Preclinical
• Mechanism: Inhibit MARCH7 E3 ligase activity
• Potential Applications: Neurodegeneration, cancer

Modulators of Ubiquitination

• [UPS](/cell-types/ubiquitin-proteasome-system) Modulators: Compounds that enhance or inhibit specific E3 ligases
• Combination Approaches: May synergize with other protein clearance strategies

Gene Therapy

• RNAi Approaches: Targeting MARCH7 expression in disease contexts
• AAV Delivery: Experimental approaches for CNS delivery

Key Publications

Interactions

MARCH7 interacts with several proteins involved in ubiquitination and protein quality control[@kim2013]:

• E2 Conjugating Enzymes: UBC13, UBCH5, UBCH6
• ERAD Components: SEL1L, HRD1
• Mitochondrial Proteins: PINK1, PARK2 (parkin)
• Immunological Proteins: MHC molecules, T cell receptor components

Research Directions

See Also

• [Ubiquitin-Proteasome System](/cell-types/ubiquitin-proteasome-system)
• [Protein Quality Control](/mechanisms/protein-quality-control-pathway)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pathway)
• [ER Stress Response](/mechanisms/er-stress-response-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

External Links

• [UniProt: Q9Y2G9](https://www.uniprot.org/uniprot/Q9Y2G9)
• [NCBI Gene: MARCH7](https://www.ncbi.nlm.nih.gov/gene/115004)
• [GeneCards: MARCH7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MARCH7)
• [Human Protein Atlas: MARCH7](https://www.proteinatlas.org/ENSG00000136573-MARCH7)

Background

The study of March7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References